cyclic heptapeptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-31. Numbers and descriptions here follow the published literature rather than marketing material.
The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.
Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H69N15O9 | Synthetic cyclic heptapeptide |
| Molecular mass | Approximately 1024 g/mol | Depends on counter-ion content |
| Appearance | White to off-white powder | Commonly supplied as a lyophilised solid |
| Solubility | Freely soluble in water | Also dissolves in common aqueous buffers |
| Typical storage | -20 degrees Celsius, desiccated | Protect from light and repeated freeze-thaw |
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
** Indicates an Imperial Fortress † Bermuda and Halifax were linked, under the Commander-in-Chief at Halifax, with units and strength at Bermuda included in figures for Halifax In February 1855 the new Secretary of State for War was additionally commissioned as Secretary at War, thus giving the Secretary of State oversight of the War Office in addition to his own department. The same procedure was followed for each of his successors, until the office of Secretary at War was abolished altogether in 1863. In 1855 the Board of Ordnance was abolished as a result of its perceived poor performance during the Crimean War. This powerful independent body, dating from the 15th century, had been directed by the Master-General of the Ordnance, usually a very senior military officer who (unlike the Secretary at War) was often a member of the Cabinet. The disastrous campaigns of the Crimean War resulted in the consolidation of all administrative duties in 1855 as subordinate to the Secretary of State for War, a Cabinet job. He was not, however, solely responsible for the Army; the Commander-in-Chief had a virtually equal degree of responsibility. This was reduced in theory by the reforms introduced by Edward Cardwell in 1870, which subordinated the Commander-in-Chief to the Secretary for War. In practice, however, a large influence was retained by the conservative Commander-in-Chief Field Marshal Prince George, 2nd Duke of Cambridge, who held the post between 1856 and 1895.
In 2005, James co-authored a paper that suggested N-acetylcysteine and glutathione ethyl ester might be useful as prophylactics for those receiving vaccines containing the preservative thiomersal. This suggestion was based on an in-vitro study in which human neuroblastoma and glioblastoma cells were directly exposed to high levels of thiomersal with and without doses of N-acetylcysteine, glutathione ethyl ester and other test substances. It is scientific consensus that the thiomersal used as a preservative in vaccines is not harmful.
On February 12, 2015, FIFA renewed the United States and Canadian broadcasting rights contracts for Fox Sports (U.S. English), Telemundo Deportes (U.S. Spanish), and Bell Media (Canada) to cover the 2026 World Cup, without accepting any other bids. A report in The New York Times asserted that this extension was intended as compensation for the rescheduling of the 2022 World Cup to November–December rather than its traditional June–July scheduling, as it created considerable conflicts with major professional sports leagues that were normally in their offseasons during the World Cup.
== Applications == 3-Fluoroalanine produced using the radioactive 18F isotope has potential applications in Positron Emission Tomography as a radioactive tracer. The D-enantiomer has shown promise in differentiating between bacterial infection and sterile inflammation. A deuterated L-enantiomer expressed enhanced tumour uptake, warranting further biological investigation into its use as a cancer imaging agent. 3-Fluoroalanine is described as unstable and generally unsuitable for peptide synthesis. Under basic conditions, it is prone to dehydrofluorination, and the proximity of the fluorine substituent to the amine group reduces the nucleophilicity of the latter. However, it has been successfully used in developing analogues to the immunosuppressant Cyclosporin A. Additionally, dehydrofluorination of 3-fluoroalanine produces a double-bond, providing a route for further amino acid functionalisation. In 2015, the synthesis of N-Fmoc-protected 3-fluoroalanine grants viable routes towards incorporating fluorinated alanine probes within synthetic peptides.
=== Religions === Some religions believe that one is not supposed to consume a non-medical, psychoactive substance, or believe that one is not supposed to consume a substance that is addictive. The Seventh-day Adventist Church asked for its members to "abstain from caffeinated drinks", but has removed this from baptismal vows (while still recommending abstention as policy). The Church of Jesus Christ of Latter-day Saints has said the following with regard to caffeinated beverages: "... the Church revelation spelling out health practices (Doctrine and Covenants 89) does not mention the use of caffeine. The Church's health guidelines prohibit alcoholic drinks, smoking or chewing of tobacco, and 'hot drinks' – taught by Church leaders to refer specifically to tea and coffee." Gaudiya Vaishnavas generally also abstain from caffeine, because they believe it clouds the mind and overstimulates the senses. To be initiated under a guru, one must have had no caffeine, alcohol, nicotine or other drugs, for at least a year. Caffeinated beverages are widely consumed by Muslims. In the 16th century, some Muslim authorities made unsuccessful attempts to ban them as forbidden "intoxicating beverages" under Islamic dietary laws.
Sources: en.wikipedia.org
=== Obsessive–compulsive disorder === In Canada, SSRIs are a first-line treatment of adult obsessive–compulsive disorder (OCD). In the UK, they are first-line treatment only with moderate to severe functional impairment and as second-line treatment for those with mild impairment, though, as of early 2019, this recommendation is being reviewed. SSRIs are more effective than placebo for reducing OCD symptoms and global severity in children and adolescents, and combining them with exposure therapy is probably more effective than using an SSRI alone.
Reform UK councillor Sean Matthews is selected to be the new leader of Lincolnshire County Council. Luke Shingler, Reform UK councillor for Nuneaton's Galley Common on Warwickshire County Council, leaves the party to sit as an independent. 12 May – Adrian Ramsay and Ellie Chowns launch a joint campaign to become co-leaders of the Green Party of England and Wales in the upcoming leadership election. 13 May – Labour MP Tahir Ali is being investigated by the Independent Parliamentary Standards Authority over excessive expenses. Conservative MP Patrick Spencer is charged with two sexual assaults that allegedly took place at London's Groucho Club. MSPs vote 70–56 in an initial vote to accept the principles of the Assisted Dying for Terminally Ill Adults (Scotland) Bill, which would allow assisted dying in Scotland. Reform UK leader Nigel Farage says he will not stand in the 2026 Senedd election and has no plans to lead the party in Wales. 14 May – The Crown Prosecution Service announces that ex-Reform MP Rupert Lowe will not face charges over alleged threats to party chairman Zia Yusuf. 15 May – Lowe, who was suspended from the Reform UK party in March, accuses Farage of running the party like a cult. 16 May – Welsh Conservatives leader Darren Millar tells his party's annual conference that the Conservatives may need to work with Plaid Cymru or Reform UK to form a government following the next Senedd election. 17 May – Darren Millar describes Reform UK as a "one-man personality cult" with no serious solution for Wales.
Sulfur dioxide is sometimes used as a preservative for dried apricots, dried figs, and other dried fruits, owing to its antimicrobial properties and ability to prevent oxidation, and is called E220 when used in this way in Europe. As a preservative, it maintains the colorful appearance of the fruit and prevents rotting. Historically, molasses was "sulfured" as a preservative and also to lighten its color. Treatment of dried fruit was usually done outdoors, by igniting sublimed sulfur and burning in an enclosed space with the fruits. Fruits may be sulfured by dipping them into sodium bisulfite, sodium sulfite or sodium metabisulfite.
Chilblains, also known as pernio, is a medical condition in which damage occurs to capillary beds in the skin, most often in the hands or feet, when blood perfuses into the nearby tissue, resulting in redness, itching, inflammation, and possibly blisters. It occurs most frequently when predisposed individuals, predominantly women, are exposed to cold and humidity. Ulcerated chilblains are referred to as kibes. Temperature-related chilblains can be prevented by keeping the feet and hands warm in cold weather and avoiding exposing these areas to extreme temperature changes. Once the diagnosis of chilblains is made, first-line treatment includes avoiding cold, damp environments and wearing gloves and warm socks. Chilblains can be idiopathic (spontaneous and unrelated to another disease), but similar symptoms may also be a manifestation of another serious medical condition that must be investigated. Related medical conditions include Raynaud syndrome, erythromelalgia, frostbite, and trench foot, as well as connective tissue diseases such as lupus or vasculitis. In infants affected by Aicardi–Goutières syndrome (a rare inherited condition which affects the nervous system), chilblain-like symptoms occur together with severe neurologic disturbances and unexplained fevers.
Sources: en.wikipedia.org
=== o-Ribosome === In 2005, three sets of ribosomes were published, which did not recognize natural mRNA, but instead translated a separate pool of orthogonal mRNA (o-mRNA). This was achieved by changing the recognition sequence of the mRNA, the Shine-Dalgarno sequence, and the corresponding recognition sequence in the 16S rRNA of ribosomes, the so-called Anti-Shine-Dalgarno-Sequence. This way the base pairing, which is usually lost if either sequence is mutated, stays available. However the mutations in the 16S rRNA were not limited to the obviously base-pairing nucleotides of the classical Anti-Shine-Dalgarno sequence.
Heseltine asked for his dissent to be minuted, and this was not done, although Cabinet Secretary Robert Armstrong stated that this had been an error and added it himself. On Monday 16 December Heseltine sat on the front bench with obvious disapproval when Brittan told the House that it was up to Westland to decide; on Wednesday 18 December he won the backing of the Commons Defence Committee for the European Consortium. On Thursday 19 December the matter was discussed at Cabinet for ten minutes: Cabinet approved leaving the decision to Westland and Heseltine was ordered to cease campaigning for the European option. Heseltine had failed to drum up enough support among possible allies like Tebbit, Howe, Walker, Norman Fowler and Tom King. A ministerial colleague at the time described him as "absolutely looney, completely hyped up with the thing" and of having a "persecution mania".
Hemoglobin-based oxygen carriers (HBOCs) Palmer's lab identifies new ways to build HBOCs. Their design strategy focus on increasing the molecular diameter of HBOCs so they're unable to traverse across blood vessel walls into the tissue space and limit negative side-effects. Supporting Publications:
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide and an analogue of alpha-melanocyte-stimulating hormone. The molecule is produced by chemical synthesis rather than extracted from a biological source.
It is shorter than the native hormone and carries a cyclic constraint that improves stability. These changes raise receptor potency and slow breakdown relative to the naturally occurring peptide.
Published accounts date its development to the 1980s, when researchers were generating analogues of melanocyte-stimulating hormone. That work aimed to produce more stable compounds for studying pigmentation biology.
It is a synthetic cyclic heptapeptide and a non-selective melanocortin receptor agonist. Structurally it is modelled on alpha-melanocyte-stimulating hormone, a peptide that occurs naturally in the body.